日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Seborova et al. Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer. Cancers 2021, 13, 1839

更正:Seborova 等人,《非编码 RNA 作为上皮性卵巢癌肿瘤进展和转移扩散的生物标志物》,Cancers 2021, 13, 1839

Seborova, Karolina; Vaclavikova, Radka; Rob, Lukas; Soucek, Pavel; Vodicka, Pavel

Molecular impact of NOTCH signaling dysregulation on ovarian cancer progression, chemoresistance, and taxane response

NOTCH信号通路失调对卵巢癌进展、化疗耐药性和紫杉烷类药物反应的分子影响

Koucka, Kamila; Spalenkova, Alzbeta; Seborova, Karolina; Tesarova, Tereza; Ehrlichova, Marie; Krus, Ivona; Holy, Petr; Rob, Lukas; Hruda, Martin; Bouda, Jiri; Bartakova, Alena; Smoligova, Vendula; Ojima, Iwao; Chen, Lei; Bendale, Hersch; Mrhalova, Marcela; Kopeckova, Katerina; Soucek, Pavel; Vaclavikova, Radka

Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma

第三代紫杉烷类药物SB-T-121605和SB-T-121606对胰腺导管腺癌有效。

Tomas Sychra ,Alzbeta Spalenkova ,Stepan Balatka ,Radka Vaclavikova ,Karolina Seborova ,Marie Ehrlichova ,Jaroslav Truksa ,Cristian Sandoval-Acuña ,Vlasta Nemcova ,Arpad Szabo ,Kamila Koci ,Tereza Tesarova ,Lei Chen ,Iwao Ojima ,Martin Oliverius ,Pavel Soucek

Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma

端粒长度作为卵巢癌患者治疗反应和生存的预测指标

Kristyna Tomasova, Karolina Seborova, Michal Kroupa, Josef Horak, Miriam Kavec, Ludmila Vodickova, Lukas Rob, Martin Hruda, Marcela Mrhalova, Alena Bartakova, Jiri Bouda, Thomas Fleischer, Vessela N Kristensen, Pavel Vodicka, Radka Vaclavikova

Association of lncRNA and transcriptome intersections with response to targeted therapy in metastatic renal cell carcinoma

lncRNA与转录组交叉点与转移性肾细胞癌靶向治疗反应的关联

Tereza Tesarova ,Kamila Koucka ,Radka Vaclavikova ,Karolina Seborova ,Milan Hora ,Ondrej Hes ,Kristyna Pivovarcikova ,Pavel Soucek ,Ondrej Fiala

Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model

含有第三代紫杉烷类药物SB-T-121605和SB-T-121606的抗癌方案在耐药性卵巢癌模型中疗效显著。

Seborova, Karolina; Koucka, Kamila; Spalenkova, Alzbeta; Holy, Petr; Ehrlichova, Marie; Sychra, Tomas; Chen, Lei; Bendale, Hersh; Ojima, Iwao; Sandoval-Acuña, Cristian; Truksa, Jaroslav; Soucek, Pavel; Vaclavikova, Radka

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

上皮性卵巢癌患者DNA修复基因的复杂分子谱与对铂类药物治疗的敏感性呈正相关

Seborova, Karolina; Hlavac, Viktor; Holy, Petr; Bjørklund, Sunniva S; Fleischer, Thomas; Rob, Lukas; Hruda, Martin; Bouda, Jiri; Mrhalova, Marcela; Allah, Mohammad Moufaq Khatar Al Obeed; Vodicka, Pavel; Fiala, Ondrej; Soucek, Pavel; Kristensen, Vessela N; Vodickova, Ludmila; Vaclavikova, Radka

Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer

非编码RNA作为上皮性卵巢癌肿瘤进展和转移扩散的生物标志物

Seborova, Karolina; Vaclavikova, Radka; Rob, Lukas; Soucek, Pavel; Vodicka, Pavel

The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes

TRIP6、ABCC3和CPS1表达在卵巢癌对紫杉烷类药物耐药中的作用

Karolina Seborova, Alzbeta Kloudova-Spalenkova, Kamila Koucka, Petr Holy, Marie Ehrlichova, Changwei Wang, Iwao Ojima, Iveta Voleska, Petr Daniel, Kamila Balusikova, Michael Jelinek, Jan Kovar, Lukas Rob, Martin Hruda, Marcela Mrhalova, Pavel Soucek, Radka Vaclavikova

DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome

DNA修复与卵巢癌发生:对风险、预后和治疗结果的影响

Tomasova, Kristyna; Cumova, Andrea; Seborova, Karolina; Horak, Josef; Koucka, Kamila; Vodickova, Ludmila; Vaclavikova, Radka; Vodicka, Pavel